Charles River Laboratories | CRL - Operating Expenses


Charles River Laboratories reported $875.93M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Align Technology USD 862.03M 39.18M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Cardinal Health USD -2.83B 52M Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cigna USD 42.21B 497.12M Mar/2026
Concord Medical Services Hldg CNY 345.26M 153.27M Jun/2025
CVS Health USD 95.75B 7.84B Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Elevance Health USD 43.9B 5.26B Mar/2026
Humana USD 37.89B 4.57B Mar/2026
Illumina USD 852M 51M Mar/2026
Incyte USD 5.62B 4.5B Mar/2026
Intrexon USD 61.56M 26.1M Jun/2024
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Laboratory Of America USD 3.13B 6.3M Mar/2026
Lakefront Biotherapeutics EUR 70.18M 50.08M Mar/2026
Lonza CHF 2.9B 184M Jun/2025
McKesson USD 94.46B 10.04B Mar/2026
Merck EUR 4.09B 687M Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Pfizer USD 90.1B 77.19B Mar/2026
Quest Diagnostics USD 2.5B 76M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
United Therapeutics USD 5.9B 5.1B Mar/2026
UnitedHealth USD 102.68B 7.27B Mar/2026
Veradigm USD 188M 61.08M Dec/2022
Waters USD 1.12B 457.15M Mar/2026
West Pharmaceutical Services USD 2.99B 2.35B Mar/2026